Benzodiazepines, antidepressants and addiction: A plea for conceptual rigor and consistency
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The editorial by Jauhar et al. (2019) discusses the recently published concerns about “addiction” to antidepressants (mainly serotonin reuptake inhibitors and serotonin and noradrenaline reuptake inhibitors) in light of an increasing number of publications addressing antidepressant withdrawal symptoms. They (Jauhar et al., 2019) ask a crucial question (“Are antidepressants addictive?”), examine conceptual and methodological issues and arrive at a conclusion that “there is minimal evidence, using established classification systems and concepts, that antidepressants should be classified as addictive substances” (p.657). We agree with their conclusion that antidepressants are not addictive and that the main argument invoked in support of addiction to antidepressants – the presence of withdrawal symptoms – is not valid. However, we would like to point that the same standard
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Recreational, abused drugs (e.g.cannabinoids; cocaine; MDMA/ecstasy) appear to increase dopaminergic signalling in ventral striatal regions, including the nucleus accumbens, a key site of the mesolimbic reward pathway (4; 5).”
From Coming Off Prescribed Psychotropic Medications: Insights from Their Use as Recreational Drugs (2020) · cites this paper as [4]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The Kimura et al. [167] and the Suzuki et al. [160] studies highlight the clinical characteristics of supersensitivity psychosis patients in the era of SGAs: high prevalence of drug-resistance, increased risk for drug-induced movement disorders, use of high chlorpromazine-equivalent doses, and a better clinical response in patients with supersensitivity psychosis compared to patients without”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [160]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Suzuki et al. [160] examined supersensitivity psychosis in treatment-resistant schizophrenic patients and found a prevalence of 72% for at least one supersensitivity psychosis episode among those treated with SGAs (i.e., olanzapine, paliperidone, perospirone, quetiapine, and risperidone).”
From Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications (2020) · cites this paper as [160]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Addiction Is a Brain Disease, and It Matters
Leshner, A. I. (1997) · Science · doi:10.1126/science.278.5335.45 · Cited by 1,615
Should addictive disorders include non-substance-related conditions?
Potenza, M. N. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01591.x · Cited by 663 · cited 1×
“Other criteria for substance addiction include an urge or a craving that immediately precedes substance use, poor self-control over substance use, and continued substance use despite its adverse consequences (Potenza, 2006; Shaffer, 1999).”
BackgroundCurrent Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090705 · Cited by 451
Self-citationCurrent Status of Benzodiazepines
Koch-Weser, J., Greenblatt, D. J., Shader, R. I., & Abernethy, D. R. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308113090607 · Cited by 249 · cited 1×
“As noted by Greenblatt et al. (1983) almost four decades ago, “Since benzodiazepines cure neither anxiety nor insomnia, symptom recurrence can be anticipated after discontinuation of the drug” (p.357).”
BackgroundSelf-citationDrug preference and mood in humans: Diazepam
Johanson, C. E., & Uhlenhuth, E. H. (1980) · Psychopharmacology · doi:10.1007/bf00433061 · Cited by 207
Batelaan, N. M., Bosman, R. C., Muntingh, A., Scholten, W. D., Huijbregts, K. M., & van Balkom, A. J. L. M. (2017) · BMJ · doi:10.1136/bmj.j3927 · Cited by 153 · cited 1×
“Finally, if we consider the study by Batelaan et al. (2017) and its recommendation of chronic treatment of anxiety disorders, why should such treatment be justified only with antidepressants (which have their own issues) and not with benzodiazepines, when they are both associated with withdrawal…”
BackgroundMurphy, S. M., & Tyrer, P. (1991) · British Journal of Psychiatry · doi:10.1192/bjp.158.4.511 · Cited by 104 · cited 5×
“…Jauhar et al. (2019) state that “Repeated studies have indicated that around 35% of people will develop dependence, and these people appear more likely to had been taking benzodiazepines for longer periods (>5 years) and have dependence-prone personalities (Murphy and Tyrer, 1991)” (pp.655–656).”
BackgroundInfluentialSelf-administration of barbiturates and benzodiazepines: A review
Ator, N. A., & Griffiths, R. R. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90588-0 · Cited by 80 · cited 7×
“It is, in fact, difficult to induce animals to self-administer benzodiazepines (Ator and Griffiths, 1987), and people with no substance abuse history have been found unable to distinguish these medications from placebo (e.”
BackgroundInfluentialStrange bedfellows: a critical view of pathological gambling and addiction
Shaffer, H. J. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.941014451.x · Cited by 77 · cited 1×
“Other criteria for substance addiction include an urge or a craving that immediately precedes substance use, poor self-control over substance use, and continued substance use despite its adverse consequences (Potenza, 2006; Shaffer, 1999).”
Background
Cited by
Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications
Cosci, F., & Chouinard, G. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000506868 · Cited by 265
Self-citationChiappini, S., Vickers‐Smith, R., Guirguis, A., Corkery, J., Martinotti, G., & Schifano, F. (2022) · Pharmaceuticals · doi:10.3390/ph15050565 · Cited by 40
“Hence, withdrawal symptoms that occur upon the discontinuation of medications prescribed do not suggest, per se, either a substance-related [79] or an addiction disorder [80].”
BackgroundOutcome of antidepressant drug discontinuation with taperingstrips after 1–5 years
Groot, P. C., & van Os, J. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320954609 · Cited by 35
Coming Off Prescribed Psychotropic Medications: Insights from Their Use as Recreational Drugs
Schifano, F. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000507897 · Cited by 18
Gao, F., He, H., Yan, B., Yang, J., Fan, Y., Bingbing, Z., He, X., Ma, Q., Li, B., Gao, Y., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3514673 · Cited by 1
Metadata
- Authors
- Balon, R., Silberman, E. K., Starcevic, V., Cosci, F., Freire, R. C., Nardi, A. E., Rickels, K., & Shader, R.
- Affiliations
- Wayne State University (US)
- Tufts University (US)
- Sydney Medical School, University of Sydney, Sydney, nsw, Australia
- Maastricht University (NL)
- Universidade Federal do Rio de Janeiro (BR)
- Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
- University of Pennsylvania (US)
- Corresponding author
- Balon, Richard
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2019-09-26
- Volume
- 33
- Issue
- 11
- Pages
- 1467-1470
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2975675221
- Cited by
- 7
- References
- 16
- Citations by year
- 2026: 2 · 2022: 1 · 2020: 4
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Florence Research (University of Florence) (submittedVersion, other-oa)
- Florence Research (University of Florence) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- benzodiazepines, antidepressant withdrawal symptoms, serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, addiction classification, conceptual rigor
- MeSH terms
- Antidepressive Agents, Benzodiazepines, Humans, Behavior, Addictive, Conduct Disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Benzodiazepines, antidepressants and addiction: A plea for conceptual rigor and consistency. https://app.cochat.ai/papers/10.1177/0269881119878171
- The paper
- Balon, R., Silberman, E. K., Starcevic, V., Cosci, F., Freire, R. C., Nardi, A. E., Rickels, K., & Shader, R. (2019). Benzodiazepines, antidepressants and addiction: A plea for conceptual rigor and consistency. Journal of Psychopharmacology. https://doi.org/10.1177/0269881119878171
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.